Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Placebo-controlled Phase 2b Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction

Trial Profile

A Randomized, Placebo-controlled Phase 2b Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Feb 2019

At a glance

  • Drugs MEDI 6012 (Primary)
  • Indications Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms REAL-TIMI 63B
  • Sponsors MedImmune
  • Most Recent Events

    • 18 Jan 2019 Planned End Date changed from 24 Mar 2020 to 31 Mar 2020.
    • 18 Jan 2019 Planned primary completion date changed from 24 Mar 2020 to 31 Mar 2020.
    • 21 Dec 2018 Planned End Date changed from 24 Nov 2020 to 24 Mar 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top